{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","spread":"0.78","value":"0.1"},{"groupId":"OG001","spread":"0.57","value":"0"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"197"},{"groupId":"OG001","value":"196"}],"units":"Participants"}],"description":"The duration in days of patients been hospitalized for febrile neutropenia (FN) or any infection. Febrile neutropenia is defined as a single oral temperature of ≥38.3°C (101°F) or a temperature of \\>38.0°C (100.4°F) sustained for \\>1 hour and ANC \\<0.5 x 10\\^9/L on the same day.","dispersionType":"Standard Deviation","groups":[{"description":"F-627, 20 mg fixed dose pre-filled syringe, administered on Day 2 of each of 4 chemotherapy cycles.\n\nF-627: single dose pre-filled syringe","id":"OG000","title":"F-627"},{"description":"6 mg fixed dose Neulasta®, administered on Day 2 of each of 4 chemotherapy cycles\n\nNeulasta: single dose pre-filled syringe","id":"OG001","title":"Neulasta"}],"paramType":"MEAN","populationDescription":"ITT (Intent-to-Treat) population","reportingStatus":"POSTED","timeFrame":"across all 4 chemotherapy cycles (average 84 days)","title":"Duration in Days of Hospitalization","type":"SECONDARY","unitOfMeasure":"days"}